All four health funds show profits

Dr. Shulamit Levenberg hopes her work will lead to cures for degenerative diseases.

November 12, 2006 23:56


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analysis from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief


An Israel scientist has been named to Scientific American magazine's list of 50 people and organizations that have demonstrated technological leadership in research, business or policymaking. Dr. Shulamit Levenberg, 37, a biomedical and tissue-engineering researcher at the Technion, whose work aims toward creating tissues and organs for transplant in labs, hopes her work will lead to cures for degenerative diseases. Although the construction of a synthetic pancreas, heart or lung is still far off, she and her colleagues are working at the problem. They believe repairing damaged brain, cartilage or muscle tissue will come first. Levenberg, modern Orthodox and the mother of five (including a baby), spent five years as a post-doctoral re-searcher at the Massachusetts Institute of Technology, where she built biological scaffolds to coax stem cells into developing into specific cell types. Previous winners of the distinction include the founders of Google and several Nobel Prize winners. Learning how they develop into different types of cells is a challenge and will supply a great deal of information on fetal development and the creation of blood vessels that nurture tissue, she says.

Related Content

[illustrative photo]
September 24, 2011
Diabetes may significantly increase risk of dementia


Cookie Settings